Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria

Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria

<p>Abstract</p> <p>Background</p> <p>Detection of lipoarabinomannan (LAM), a <it>Mycobacterium tuberculosis </it>(<it>Mtb</it>) cell wall antigen, is a potentially attractive diagnostic. However, the LAM-ELISA assay has demonstrated variable sens...

Full description

Bibliographic Details
Main Authors:	Wood Robin, Racow Kimberly, Bekker Linda-Gail, Middelkoop Keren, Vogt Monica, Kreiswirth Barry N, Lawn Stephen D
Format:	Article
Language:	English
Published:	BMC 2012-02-01
Series:	BMC Infectious Diseases
Online Access:	http://www.biomedcentral.com/1471-2334/12/47

Similar Items

Indoor social networks in a South African township: potential contribution of location to tuberculosis transmission.
by: Robin Wood, et al.
Published: (2012-01-01)

Prognostic value of a quantitative analysis of lipoarabinomannan in urine from patients with HIV-associated tuberculosis.
by: Andrew D Kerkhoff, et al.
Published: (2014-01-01)

Urine lipoarabinomannan testing in children with tuberculosis
by: Ben J Marais
Published: (2014-05-01)

Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review
by: Lawn Stephen D
Published: (2012-04-01)

Burden of new and recurrent tuberculosis in a major South African city stratified by age and HIV-status.
by: Robin Wood, et al.
Published: (2011-01-01)

Combining urine lipoarabinomannan with antibody detection as a simple non-sputum-based screening method for HIV-associated tuberculosis.
by: Hiba Younis, et al.
Published: (2019-01-01)

The Diagnostic Value of Urine Lipoarabinomannan (Lam) Antigen in Childhood Tuberculosis
by: Agustin Iskandar, et al.
Published: (2017-03-01)

TB transmission is associated with prolonged stay in a low socio-economic, high burdened TB and HIV community in Cape Town, South Africa
by: Rebecca Tadokera, et al.
Published: (2020-02-01)

Urine lipoarabinomannan for rapid tuberculosis diagnosis in HIV-infected adult outpatients in Khayelitsha
by: Bianca Sossen, et al.
Published: (2021-04-01)

Urine lipoarabinomannan testing for diagnosis of pulmonary tuberculosis in children: a prospective study
by: Prof. Mark P Nicol, PhD, et al.
Published: (2014-05-01)

Investigation of urine lipoarabinomannan in human immunodeficiency virus patients with or without coinfection with Tuberculosis in Iran
by: Payam Tabarsi, et al.
Published: (2016-01-01)

Diagnostic Accuracy of Urine Lipoarabinomannan Testing in Early Morning Urine versus Spot Urine for Diagnosis of Tuberculosis among People with HIV
by: Stephanie Bjerrum, et al.
Published: (2022-04-01)

A systematic review of utility of urine lipoarabinomannan in detecting tuberculosis among HIV-positive tuberculosis suspects
by: Chakrapani Chatla, et al.
Published: (2021-01-01)

Biomarkers for tuberculosis: the case for lipoarabinomannan
by: Margarida Correia-Neves, et al.
Published: (2019-02-01)

Lateral flow urine lipoarabinomannan assay for extrapulmonary tuberculosis diagnosis in adults who are HIV-positive
by: Ni Nyoman Indirawati, et al.
Published: (2022-09-01)

The diagnostic accuracy of urine lipoarabinomannan test for tuberculosis screening in a South African correctional facility.
by: Yasmeen Hanifa, et al.
Published: (2015-01-01)

Role of detection of lipoarabinomannan (LAM) in urine for diagnosis of pulmonary tuberculosis in HIV patients: Egyptian experience
by: Nagwa Elhalawany, et al.
Published: (2021-04-01)

Positive Lateral Flow Urine Lipoarabinomannan Assay (LF-LAM) Result in Detection of Active Tuberculosis
by: Sara Puspita, et al.
Published: (2021-09-01)

Force of tuberculosis infection among adolescents in a high HIV and TB prevalence community: a cross-sectional observation study
by: Sebastian Elaine, et al.
Published: (2011-06-01)

DIAGNOSTIC ACCURACY OF LIPOARABINOMANNAN DETECTION IN PLEURAL TUBERCULOSIS
by: A. Mohapatra, et al.
Published: (2023-05-01)

Lipoarabinomannan in Active and Passive Protection Against Tuberculosis
by: Margarida Correia-Neves, et al.
Published: (2019-09-01)

A sensitive urinary lipoarabinomannan test for tuberculosis.
by: Beston Hamasur, et al.
Published: (2015-01-01)

Diagnostic utility of urinary lipoarabinomannan in pulmonary tuberculosis
by: Sahar M.T Mourad, et al.
Published: (2019-01-01)

Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patients.
by: Tobias Broger, et al.
Published: (2019-01-01)

Cost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosis.
by: Nadia Yakhelef, et al.
Published: (2020-01-01)

Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa.
by: Ankur Gupta, et al.
Published: (2013-01-01)

Interaction of amphiphilic lipoarabinomannan with host carrier lipoproteins in tuberculosis patients: Implications for blood-based diagnostics.
by: Shailja Jakhar, et al.
Published: (2021-01-01)

Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.
by: Ankur Gupta, et al.
Published: (2012-01-01)

Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children.
by: Birgit Schramm, et al.
Published: (2021-01-01)

Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort study.
by: Ankur Gupta-Wright, et al.
Published: (2019-04-01)

Utility of the lateral flow urine lipoarabinomannan tuberculosis assay in patients with advanced HIV disease at antiretroviral therapy centres in Mumbai, India.
by: Shrikala Acharya, et al.
Published: (2022-01-01)

The opportunity and challenges associated with the development of cell-based biosensor for detection of urine mycobacterium lipoarabinomannan
by: Dian Ayu Eka Pitaloka, et al.
Published: (2024-02-01)

Antiretroviral treatment cohort analysis using time-updated CD4 counts: assessment of bias with different analytic methods.
by: Katharina Kranzer, et al.
Published: (2011-01-01)

Manipulation of the endocytic pathway and phagocyte functions by Mycobacterium tuberculosis lipoarabinomannan
by: Isabelle eVergne, et al.
Published: (2015-01-01)

Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study.
by: Stephen D Lawn, et al.
Published: (2011-07-01)

Utility of urine lipoarabinomannan (LAM) in diagnosing mycobacteria infection among hospitalized HIV-positive patients
by: Danping Liu, et al.
Published: (2022-05-01)

Estimation of D-Arabinose by Gas Chromatography/Mass Spectrometry as Surrogate for Mycobacterial Lipoarabinomannan in Human Urine.
by: Prithwiraj De, et al.
Published: (2015-01-01)

Aptamer Detection of Mycobaterium tuberculosis Mannose-Capped Lipoarabinomannan in Lesion Tissues for Tuberculosis Diagnosis
by: Yuanyuan Zhou, et al.
Published: (2021-03-01)

Diagnostic accuracy of Lipoarabinomannan detection by lateral flow assay in pleural tuberculosis
by: Atish Mohapatra, et al.
Published: (2024-02-01)

Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis
by: Jason L. Cantera, et al.
Published: (2022-01-01)